---
$id: https://graph.org.ai/products/commodity/51172202
$type: Product
source: UNSPSC
code: "51172202"
title: "Butaphosphan"
class: "51172200"
classTitle: "Drugs that treat interstitial cystitis"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butaphosphan

**UNSPSC Code**: 51172202
**Class**: [Drugs that treat interstitial cystitis](Drugs that treat interstitial cystitis.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphorous supplement with the molecular formula C7H17NO2P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3Q2LQ1149L, chemically known as 2-(butylamino)propan-2-yl-hydroxy-oxophosphanium but generally known as casanthranol, which bears US NIH Compound Identifier 6328684. BUTAPHOSPHAN, as BUTAFOSFAN, is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. European Medicines Agency schedules Butaphosphan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05997MIG. SMILES: CCCCNC(C)(C)[P+](=O)O.

